Shalini Sharp
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shalini Sharp
Earlier roles on record: CFO at Ultragenyx Pharmaceutical Inc. (RARE) until November 2, 2020. The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $2,605,521 for Shalini Sharp in fiscal 2019, including a base salary of $484,548. Disclosed compensation is on record for 3 fiscal years. Shalini Sharp has spoken on 3 earnings calls across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on October 27, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-11-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $484,548 | $2,605,521 |
| 2018 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $470,435 | $2,060,787 |
| 2017 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $455,785 | $2,642,719 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.